# Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease

> **NCT03467620** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **University of Illinois at Chicago**

## Conditions studied

- Crohn Disease
- Inflammatory Bowel Diseases
- Cannabis

## Interventions

- **DRUG:** Cannabidiol
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03467620
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-07
- **Primary completion:** 2019-07
- **Final completion:** 2019-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Inadequate funding
- **Last updated:** 2020-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03467620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03467620, "Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03467620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*